IP Library Granted Patent US 9,333,005
Granted Patent B2
US 9,333,005 · App. 13/654,216 · Granted May 10, 2016

Ultrasonic probe for treating cellulite

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,333,005
App. No.
13/654,216
Granted
May 10, 2016
Kind
B2
Abstract

An ultrasonic probe transmits ultrasonic energy along a shaft from a proximate end to a distal end. The ultrasonic probe includes at least one notch on its distal end. Fibrous tissue, such as septa that connect skin layers to muscle layers of animal tissue, can be positioned within the notch so that it is in contact with at least a portion of the distal end of the ultrasonic probe. The ultrasonic energy conducted through the ultrasonic probe to the distal end will sever the fibrous tissue in the notch. The ultrasonic probe is also designed, in embodiments, to fragment or emulsify adipose tissue, as part of an ultrasonic assisted lipoplasty (UAL) procedure.

Claims (15)

1. An ultrasonic probe for conducting ultrasonic energy to a surgical site for use in severing fibrous tissue and fragmenting adipose tissue, the ultrasonic probe comprising:

a shaft including a distal end and a proximate end configured to connect to an ultrasonic driver assembly that generates the ultrasonic energy, the shaft configured to conduct the ultrasonic energy from the proximate end to the distal end; and

a first cutting surface located proximate the distal end of the shaft,

wherein the first cutting surface is configured to contact and sever the fibrous tissue, and the first cutting surface has a center point located at a distance from the distal end of the ultrasonic probe that corresponds to an antinode of an ultrasonic longitudinal vibration pattern produced by the delivery of ultrasonic energy to the distal end of the shaft.

2. The ultrasonic probe of claim 1 , wherein the shaft comprises an outer surface, wherein the outer surface at least partially defines the cutting surface.

3. The ultrasonic probe of claim 2 , wherein the outer surface defines a substantially rounded profile and the cutting surface defines a substantially flat profile.

4. The ultrasonic probe of claim 2 , further comprising:

a second cutting surface located symmetrically on the outer surface relative to the first cutting surface.

5. The ultrasonic probe of claim 1 , further comprising:

one or more grooves near the distal end,

wherein the one or more grooves are located between the distal end of the shaft and the first cutting surface.

6. An ultrasonic probe for conducting ultrasonic energy to a surgical site for use in severing fibrous tissue and fragmenting adipose tissue, the ultrasonic probe comprising:

a probe body including a tip, a plurality of cutting edges proximate to the tip, an outer surface, and a plurality of grooves extending circumferentially about the outer surface proximate to the tip,

wherein the grooves are located between the tip and the cutting edges along a longitudinal axis of the probe body, and the cutting edges are oriented parallel to the longitudinal axis of the probe body.

7. The ultrasonic probe of claim 6 , wherein the probe body has a cross-sectional area, and the portion of the probe body including the cutting edges has a cross-sectional area that is about 95% to about 80% of the cross-sectional area of the probe body.

Assignments (18)
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
Reel/Frame 073654/0300 →
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.
Reel/Frame 073637/0126 →
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH AMERICAS, INC.
Reel/Frame 073654/0242 →
U.S. PATENT SECURITY AGREEMENT Recorded Jun 13, 2025
From: MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; BAUSCH HEALTH US, LLC (F/K/A VALEANT PHARMACEUTICALS NORTH AMERICA LLC); PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, INC.; SANTARUS, INC.; BAUSCH HEALTH AMERICAS, INC.; SOLTA MEDICAL, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 071566/0200 →
U.S. PATENT SECURITY AGREEMENT Recorded Jun 13, 2025
From: MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; BAUSCH HEALTH US, LLC (F/K/A VALEANT PHARMACEUTICALS NORTH AMERICA LLC); PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, INC.; SANTARUS, INC.; BAUSCH HEALTH AMERICAS, INC.; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 071564/0463 →
SECURITY AGREEMENT (SECOND LIEN) Recorded Oct 5, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061606/0468 →
SECURITY AGREEMENT (FIRST LIEN) Recorded Oct 4, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061595/0066 →
SECURITY INTEREST Recorded Jun 13, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON
Reel/Frame 060346/0705 →
SECURITY AGREEMENT Recorded Feb 10, 2022
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH AMERICAS, INC.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 059121/0001 →
SECURITY INTEREST Recorded Jun 8, 2021
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH AMERICAS, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 056811/0814 →
MERGER Recorded May 12, 2021
From: SOUND SURGICAL TECHNOLOGIES LLC
To: SOLTA MEDICAL, INC.
Reel/Frame 056214/0690 →
SECURITY INTEREST Recorded Mar 11, 2019
From: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 048556/0758 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Jan 27, 2014
From: SILICON VALLEY BANK
To: SOUND SURGICAL TECHNOLOGIES LLC
Reel/Frame 032127/0587 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Jan 27, 2014
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
To: SOUND SURGICAL TECHNOLOGIES LLC
Reel/Frame 032127/0129 →
SHORT-FORM PATENT SECURITY AGREEMENT Recorded Nov 19, 2013
From: SOUND SURGICAL TECHNOLOGIES, LLC
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 031674/0568 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 4, 2013
From: WESLEY, DAVE; MERCHANT, ADNAN
To: SOUND SURGICAL TECHNOLOGIES LLC
Reel/Frame 031537/0399 →
SECURITY AGREEMENT Recorded Aug 30, 2013
From: SOUND SURGICAL TECHNOLOGIES LLC
To: SILICON VALLEY BANK
Reel/Frame 031130/0574 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2012
From: SCHAFER, MARK E.
To: SOUND SURGICAL TECHNOLOGIES, LLC
Reel/Frame 029215/0672 →